Objective-To establish national clinical guidelines and integrated care pat
hways for five conditions (tuberous sclerosis (TS), Huntington's disease (H
D), myotonic dystrophy (MD), neurofibromatosis type 1 (NF1), and Marfan syn
drome (MS)) and audit their use in Scotland.
Design-Systematic review of published reports followed by consensus confere
nces to prepare clinical guidelines and integrated care pathways. Structure
d review of medical records before and after introduction of integrated car
e pathways to document changes in practice. Survey of staff views on proced
ures adopted.
Setting-All four clinical genetics centres in Scotland.
Results-Project resulted in reduced variation in practice across centres, i
mproved data recording in medical records, and improved communication with
other professional groups. A very poor evidence base for management of pati
ents with the conditions studied was found.
Conclusions A collaborative structure for undertaking clinical research wou
ld improve the evidence base for current practice. National discussion of t
he boundaries of responsibility of care for the long term management of pat
ients with these disorders is required. The integrated care pathway approac
h shows promise as a means of facilitating the development of audit within
clinical genetics services.